Buitrón R, Zarama F, Rivas R, Anda L, Romero R, Bravo R

Language: Spanish
References: 12
Page: 80-82
PDF size: 65.98 Kb.

ABSTRACT

Anovulation with inversion of FSH/LH is considered a sterility problem with a frequency of 20%. A prospective, transversal, and observational study was performed to demonstrate the effectiveness of a 75u single dose of recombinant follicle stimulating hormone (FSH) and 50 mg of clomiphene citrate per day for five days beginning in the third day and ending on the seventh day of the menstrual cycle during the initial stage of clinical study on patients with sterility. A total of 86 partners were included. Pregnancy was achieved in 17(19.76%) patients. The use of a single dose of FSH on the first day of menstrual cycle associated to clomiphene citrate in patients with a sterility problem, enhanced the ovary incorporation allowing the action of endogenous FSH and presenting the referred percentage of pregnancy in the initial stage of study.

REFERENCES

1. Anatomy and physiology of the hypothalamus and pituitary. In: Mastroianni L, Coutifaris Ch. Reproductive physiology. Lancs, UK: Parthenon Blishing Group. 1990; 11-21.

2. Gougeon A. Dinámica del crecimiento follicular en el humano: Un modelo de resultados preliminares. Hum Reprod 1986; 1: 81-87.

3. Yen SSC, Jaffe RB. El ciclo menstrual humano regulación neuroendocrina. En: Endocrinología reproductiva. 3ra ed. Philadelphia: WB Saunders, 1991; 273-308.

4. DePaolo LV, Bicsak TA, Erickson GF, Shimasake S, Ling N. Folistatina y activina; sistema regulatorio intrínseco potencial dentro de tejidos diversos. Soc Exp Biol Med 1991; 198: 500-512.

5. Kettel LM, Erickson GF. Conceptos básicos y clínicos en la inducción de ovulación. En: Rock JA (ed). Avances en obstetricia y ginecología. Vol 1. Chicago, Il: Mosby-Anuario, 1994; 211-229.

6. Lolis DE, Tsolas O, Messinis IE. The follicle stimulating hormone threshold level for follicle maturation in superovulated cycles. Fertil Steril 1995; 63 (6): 1272-1277.

7. Smitz J, Devroey P, Mannaerts B, Coeling BH, Van Steirteghem AC. The use of recombinant FSH for ovulation induction. Ann Endocrinol Paris 1994; 55 (2): 79-83.

8. Meden Vrtovec H. Pure FSH (metrodin) for ovarian stimulation in the IVF-ET programe. Clin Exp Obstet Gynecol 1995; 22 (1): 9-13.

9. Homburg R, Levy T, Ben-Rafael Z. A compative prospective study of convencional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 1995; 63 (4): 729-733.

10. Van Dessel HJ, Donderwinkel PF, Coelingh Bennink HJ, Fauser BC. First established pregnancy and birth after induction of ovulation with recombinant human follicle stimulating hormone in polycystic ovary syndrome. Hum Reprod 1994; 9 (1): 55-56.

11. Di Carlo C, Affinito P, Farace MJ, Gargiulo AR, Zullo F, Nappi C. Observations on the use of purified follicle stimulating hormone in the treatment of luteal phase defects. Hum Reprod 1995; 10 (6): 1359-1362.

12. Hayden CJ, Rutherford JA, Balen HA. Inducción de la ovulación con el uso de una dosis inicial de 50 unidades de hormona folículo estimulante humana recombinante (puregon). Fertility Sterility 1999; 71 (1): 106-108.